Barinthus Biotherapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

26.08M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	14.97M	14.17M	1,766.46%
Dec 31, 2023	802.00K	-43.90M	-98.21%
Dec 31, 2022	44.70M	44.44M	16,580.22%
Dec 31, 2021	268.00K	-4.55M	-94.44%
Dec 31, 2020	4.82M	-2.02M	-29.57%
Dec 31, 2019	6.85M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Palatin Technologies	12.88M
Kyntra Bio	7.44M
Dyadic International	3.81M
Traws Pharma	2.73M
ABVC BioPharma	797.92K
Neuphoria Therapeutics	-13.27K

Revenue Rankings

BRNS News

18 days ago - Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments - GlobeNewsWire
2 months ago - Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year - TheFly
5 months ago - Barinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000 - TheFly
6 months ago - Barinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright - TheFly
6 months ago - Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year - TheFly
7 months ago - ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics - PRNewsWire
8 months ago - BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS - Business Wire
8 months ago - Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases - GlobeNewsWire

More News